An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether early use of a bland emollient in newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the development of atopic dermatitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Oregon Health and Science University
• Collaborators: Galderma; Galderma R&D; National Eczema Association
• Treatments: Emollients

Criteria

Inclusion Criteria:

• at least one parent diagnosed with Atopic Dermatitis

• one parent or sibling with hayfever or asthma

Exclusion Criteria:

• newborns with dermatitis at birth

• newborns born greater than four weeks prematurely

• newborns with medical problems necessitating prolonged hospitalization

• newborns diagnosed with any immune deficiency syndrome